Cargando…
The USP10-HDAC6 axis confers cisplatin resistance in non-small cell lung cancer lacking wild-type p53
Ubiquitin-specific peptidase 10 (USP10) stabilizes both tumor suppressors and oncogenes in a context-dependent manner. However, the nature of USP10’s role in non-small cell lung cancer (NSCLC) remains unclear. By analyzing The Cancer Genome Atlas (TCGA) database, we have shown that high levels of US...
Autores principales: | Hu, Chen, Zhang, Mu, Moses, Niko, Hu, Cong-li, Polin, Lisa, Chen, Wei, Jang, Hyejeong, Heyza, Joshua, Malysa, Agnes, Caruso, Joseph A., Xiang, Shengyan, Patrick, Steve, Stemmer, Paul, Lou, Zhenkun, Bai, Wenlong, Wang, Chuangui, Bepler, Gerold, Zhang, Xiaohong Mary |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7206099/ https://www.ncbi.nlm.nih.gov/pubmed/32382008 http://dx.doi.org/10.1038/s41419-020-2519-8 |
Ejemplares similares
-
HDAC6 Regulates Radiosensitivity of Non-Small Cell Lung Cancer by Promoting Degradation of Chk1
por: Moses, Niko, et al.
Publicado: (2020) -
Depletion of HDAC6 Enhances Cisplatin-Induced DNA Damage and Apoptosis in Non-Small Cell Lung Cancer Cells
por: Wang, Lei, et al.
Publicado: (2012) -
Implications of the USP10-HDAC6 axis in lung cancer - A path to precision medicine
por: Zhang, Xiaohong Mary, et al.
Publicado: (2016) -
The Mechanisms of Zinc Action as a Potent Anti-Viral Agent: The Clinical Therapeutic Implication in COVID-19
por: Prasad, Ananda S., et al.
Publicado: (2022) -
Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells
por: Arora, Sanjeevani, et al.
Publicado: (2016)